Watch the Demo
Learn how to use the Strep A 2 test by watching this product demonstration.
Global Point of Care
ID NOW™
MOLECULAR. IN MINUTES.
Rapid, Molecular Results at the Point of Care
The ID NOW™ Platform is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique ID NOW™ isothermal nucleic acid amplification technology (NAAT) provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.
ID NOW™ Instrument
ID NOW™
MOLECULAR. IN MINUTES.
Rapid, Molecular Results at the Point of Care
The ID NOW™ Platform is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique ID NOW™ isothermal nucleic acid amplification technology (NAAT) provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.
Benefits
The intuitively designed ID NOW™ instrument can have a positive impact in any healthcare setting.
- Easy to use with only minimal training requirements
- Large visual touchscreen displays results, eliminating transcription errors and the need for printing
- Small footprint saves you bench space and can be used in any healthcare setting
- QC lock-out
- Bi-directional connectivity
- Offers exceptional performance
- Gives you the confidence to make clinical decisions sooner
- Facilitates effective patient management
- Enables prompt initiation of infection control measures
- Aids targeted antiviral therapy and Antimicrobial Stewardship
- Reliable near-patient testing reduces overall healthcare costs1
SIMPLE AND SECURE RESULTS REPORTING
Track, consolidate and report ID NOW™ test results from multiple decentralized instruments and locations using RALS™.
Illuminating Insights: Rapid Molecular Testing for Respiratory Disease
Rapid molecular testing is an important tool in the fight against respiratory infectious disease. The ID NOW™ platform can lead to faster diagnosis and better overall patient care.
ID NOW™ is significantly faster than other molecular methods and more accurate than conventional rapid tests.
Helpful Documents
PRODUCT DOCUMENTS
PRODUCT CODE
| ID NOW™ System | Code |
|---|---|
| ID NOW™ Instrument | NAT-024 |
| ID NOW™ COVID-19 2.0 Test Kit | 192-000 |
| ID NOW™ COVID-19 2.0 Control Kit | 192-080 |
| ID NOW™ Influenza A & B 2 24 Test Kit | 427-000 |
| ID NOW™ Influenza A & B Control Swab Kit | 425-080 |
| ID NOW™ Strep A 2 24 Test Kit | 734-000 |
| ID NOW™ Strep A 2 Control Swab Kit | 734-080 |
| ID NOW™ RSV 24 Test Kit | 435-000 |
| ID NOW™ RSV Control Swab Kit | 435-080 |
| ID NOW™ Barcode Scanner | L22XWU1200 |
| Universal Printer | IDNOWPRINT |
Videos
Watch the Technology Video
Learn how Abbott utilizes unique isothermal nucleic acid amplification technology.
View References
- Bonner, A.B. et al. (2003) Impact of the Rapid Diagnosis of Influenza on Physician Decision-Making and Patient Management in the Pediatric Emergency Department: Results of a Randomized, Prospective, Controlled Trial. Pediatrics Vol. 112 No. 2.